CINECA IRIS Institutional Research Information System

FERRO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.607
AS - Asia 2.772
EU - Europa 1.835
SA - Sud America 485
AF - Africa 189
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.896
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.501
SG - Singapore 930
CN - Cina 740
IT - Italia 505
SE - Svezia 427
HK - Hong Kong 403
BR - Brasile 400
VN - Vietnam 315
DE - Germania 217
BG - Bulgaria 153
GB - Regno Unito 116
FR - Francia 98
RU - Federazione Russa 76
CA - Canada 74
IN - India 74
CI - Costa d'Avorio 70
FI - Finlandia 70
JP - Giappone 47
TR - Turchia 47
AR - Argentina 39
SN - Senegal 34
IQ - Iraq 29
AT - Austria 28
BD - Bangladesh 23
NL - Olanda 23
ZA - Sudafrica 23
KR - Corea 22
PL - Polonia 21
NG - Nigeria 20
ID - Indonesia 19
UZ - Uzbekistan 19
UA - Ucraina 18
MX - Messico 17
ES - Italia 16
MA - Marocco 15
BE - Belgio 12
PK - Pakistan 12
KE - Kenya 11
SA - Arabia Saudita 10
VE - Venezuela 10
EC - Ecuador 9
LT - Lituania 9
PH - Filippine 9
AZ - Azerbaigian 7
CO - Colombia 7
MY - Malesia 7
PY - Paraguay 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
IE - Irlanda 6
JO - Giordania 6
AM - Armenia 5
CH - Svizzera 5
CL - Cile 5
IR - Iran 5
NP - Nepal 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
KG - Kirghizistan 4
PS - Palestinian Territory 4
RS - Serbia 4
UY - Uruguay 4
AL - Albania 3
AU - Australia 3
HU - Ungheria 3
LK - Sri Lanka 3
LV - Lettonia 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
TN - Tunisia 3
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
GD - Grenada 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
PE - Perù 2
SI - Slovenia 2
SR - Suriname 2
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
Totale 9.885
Salva come PNG Salva come JPEG
Città #
Dallas 678
Ashburn 546
Singapore 524
San Jose 394
Hong Kong 393
Santa Clara 339
Chandler 198
Woodbridge 196
Shanghai 186
Fairfield 165
Sofia 150
Beijing 147
Houston 141
Ann Arbor 132
New York 132
Boardman 114
Los Angeles 100
Ho Chi Minh City 96
Seattle 89
Milan 85
Munich 84
Princeton 77
Wilmington 77
Abidjan 70
Hanoi 63
Lawrence 63
Florence 62
Cambridge 57
Medford 53
Frankfurt am Main 46
Serra 46
Lauterbourg 43
Ottawa 42
São Paulo 39
Tokyo 39
Hefei 38
London 38
Redondo Beach 37
Turku 37
Dakar 34
Council Bluffs 30
Dearborn 29
Des Moines 28
Istanbul 27
Nanjing 23
Rome 22
Vienna 22
Buffalo 21
Lagos 20
Dong Ket 19
Pune 19
Bremen 17
Düsseldorf 17
Pisa 17
Seoul 17
Atlanta 16
Denver 16
Ogden 16
San Diego 16
Chicago 15
Tashkent 15
Baghdad 14
Belo Horizonte 14
Mumbai 14
Orem 14
Warsaw 14
Montreal 13
Trani 13
Boulder 12
Brussels 12
Cascina 12
Fuzhou 12
Guangzhou 12
Helsinki 12
Brooklyn 11
Redwood City 11
Rio de Janeiro 11
San Francisco 11
Haiphong 10
Jacksonville 10
Marseille 10
Nairobi 10
Poplar 10
Columbus 9
Izmir 9
Nanchang 9
Norwalk 9
Nuremberg 9
Stockholm 9
Boston 8
Da Nang 8
Falls Church 8
Hebei 8
Johannesburg 8
Leicester 8
Phoenix 8
Quanzhou 8
The Dalles 8
Arezzo 7
Baltimore 7
Totale 6.674
Salva come PNG Salva come JPEG
Nome #
Correspondence between salivary proteomic pattern and clinical course in primary Sjogren syndrome and non-Hodgkin's lymphoma: a case report 225
Autoimmune diseases and myeloid hematological disorders: a possible pathogenetic relationship 210
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 204
miRNA-mediated regulation of Mucin-type O-Glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren's syndrome 183
A Clinical Prediction Rule for Lymphoma Development in Primary Sjogren's Syndrome 182
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 181
Biomarkers for Sjögren's syndrome 172
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience. 171
Ultra-High Frequency Ultrasound, A Promising Diagnostic Technique: Review of the Literature and Single-Center Experience 170
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome. 160
The association of Sjögren syndrome and autoimmune thyroid disorders 159
Classification criteria in Sjögren’s syndrome 157
Myeloid neoplasms and autoimmune diseases: markers of association 152
Eosinophilic granulomatosis with polyangiitis with heterozygous familial hypercholesterolemia: A tricky therapeutic approach with omalizumab and evolocumab 149
Histidine proline rich glycoprotein (HPRG) e sindrome di Sjoegren primitiva: un ruolo patogenetico nella formazione degli infiltrati ghiandolari? 147
COVID-19: the new challenge for rheumatologists 147
Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome 145
Ultra-High Frequency Ultrasound (Uhfus) Applications in Sjogren Syndrome: Narrative Review and Current Concepts 145
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EOSINOPHILOIA IN EGPA FROM HES 144
Advances in salivary gland ultrasonography in primary Sjögren's syndrome 140
THU0264 MYELOID MALIGNANCIES, SYSTEMIC AUTOIMMUNE DISEASES AND CARDIOVASCULAR RISK: AN UNDER-REPORTED ASSOCIATION? 140
Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience 139
Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation? 138
One year in review 2019: Sjögren’s syndrome 137
The CoV-2 outbreak: how hematologists could help to fight Covid-19 136
CLINICAL AND BIOLOGICAL FEATURES DISTINGUISH MYELOID DISEASES FROM MYELOID DISORDERS ASSOCIATED WITH AUTOIMMUNE DISEASES. 135
COVID-19: the new challenge for rheumatologists. First update 134
One year in review 2018: Sjögren's syndrome 133
Cryoglobulinemic vasculitis: a 2023 update 132
MicroRNA-mediated Regulation ofMucin-type O-glycosylation Pathway: A Putative Mechanism of Salivary Gland Dysfunction in Sjögren Syndrome 130
One year in review: the pathogenesis of rheumatoid arthritis 129
Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren's Syndrome 128
Pregnancy and undifferentiated connective tissue disease: outcome and risk of flare in 100 pregnancies 128
Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review 128
One year in review 2020: vasculitis 127
Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome 125
Ultra-high frequency ultrasonography (UHFUS)-guided minor salivary gland biopsy: A promising procedure to optimize labial salivary gland biopsy in Sjögren’s syndrome 123
One year in review 2019: vasculitis 122
Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison 121
Systemic vasculitis: an annual critical digest of the most recent literature 118
Ocular Surface Disease Index (OSDI): a potential useful instrument for the assessment of vision-targeted health-related quality of life (VT-HRQ) in primary Sjogren's syndrome (pSS) clinical trials? 117
Translation, cultural adaptation and validation of the Italian version of the Brief Index of Lupus Damage: the BILDit 116
Ocular Surface Disease Index (OSDI): a potential useful instrument for the assessment of vision-targeted health-related quality of life (VT-HRQ) in primary Sjögren's syndrome (pSS) clinical trials? 111
Ultra-high frequency ultrasonography of labial glands is a highly sensitive tool for the diagnosis of Sjögren's syndrome: a preliminary study 111
One year in review: systemic vasculitis 109
Severe Eosinophilic Asthma or Eosinophilic Granulomatosis With Polyangiitis: Potential Biomarkers for Novel Diagnostic Strategies 108
Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren's syndrome and related lymphoproliferation: results in independent cohorts 108
One year in review 2016: Sjögren's syndrome 105
One year in review 2021: systemic vasculitis 105
Salivary Proteomics Markers for Preclinical Sjögren’s Syndrome: A Pilot Study 104
One year in review 2017: novelties in the treatment of rheumatoid arthritis 103
Salivary Proteomics and Churg-Strauss Syndrome: A Phase IIa Case-Control Study Aimed At Identifying Novel Diagnostic Disease Biomarkers. 101
Ultrasonography of major salivary glands: a highly specific tool for distinguishing primary Sjögren's syndrome from undifferentiated connective tissue diseases. 101
Sjögren's Syndrome: The Clinical Spectrum of Male Patients 98
Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology 97
Behçet's syndrome and psychiatric involvement: is it a primary or secondary feature of the disease 96
Update on the pathophysiology and treatment of primary Sjögren syndrome 94
Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit 93
Pleural Irregularities: A new ultrasound marker for lung involvement in primary Sjögren's disease 93
In Vivo Confocal Microscopic Evaluation of Corneal Morphology and Innervation in Primary Sjögren’s Syndrome and Non-SS Dry Eye: A Monocentric Cross Sectional Study 93
One year in review 2021: Sjögren's syndrome 93
Systemic vasculitis: one year in review 2024 92
One year in review 2020: pathogenesis of primary Sjögren's syndrome 92
One year in review 2017: primary Sjögren's syndrome 88
null 86
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome 85
Idiopathic inflammatory myopathies and COVID-19: an intriguing liaison? 82
Systemic vasculitis: one year in review 2023 81
Imaging in primary Sjögren's syndrome: the 'obsolete and the new' 80
null 78
Total area of inflammatory infiltrate and percentage of inflammatory infiltrate identify different clinical-serological subsets of primary Sjögren's syndrome better than traditional histopathological parameters 77
The role of tobacco smoking in anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic review 76
null 74
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 72
Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy 71
Correspondence between minor salivary glands ultra-high frequency ultrasonography and histology: a case report of severe/atypical lymphoid infiltrate in Sjögren's syndrome 68
The use of ultrasound for assessing interstitial lung involvement in connective tissue diseases 66
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease 66
Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording 62
null 61
null 60
Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development 60
Clinical and histological features of patients with primary Sjögren's syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study 60
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 58
Impact of gender and age at onset on Sjögren's syndrome presentation and outcome: state of the art 57
{SAT}0175{\hspace{0.25em}}{ULTRA}-{HIGH}-{FREQUENCY} {ULTRASOUND} {OF} {LABIAL} {SALIVARY} {GLANDS} {HIGHLY} {CORRELATES} {WITH} {HISTOPATHOLOGY} {IN} {PRIMARY} {SJÃGREN}'S {SYNDROME} 47
null 46
null 40
Systemic vasculitis: one year in review 2025 39
GPA and EGPA: Comparison of the 1990 ACR Criteria With the 2022 ACR/EULAR Criteria in a Monocentric Cohort of Patients 34
Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases 24
Immunosuppressive Therapy for Usual Interstitial Pneumonia in Autoimmune Rheumatic Diseases: A Review 23
null 20
Totale 10.127
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.449
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 0 28 83
2021/2022752 17 43 5 63 139 94 21 48 33 34 58 197
2022/2023966 157 150 68 52 74 94 19 62 189 3 84 14
2023/2024739 62 61 73 42 127 146 50 19 10 24 38 87
2024/20252.476 10 71 45 126 239 367 199 114 192 288 356 469
2025/20263.684 294 418 689 343 420 268 499 160 207 381 5 0
Totale 10.127